Beyond Generalized Treatment: The Future is Personalized Medicine

Notice

This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.

Year : 2025 | Volume : 02 | 02 | Page :
    By

    Lakshay Virmani,

  • Simran Kumari,

  1. Student, Department of Biotechnology, Delhi Technological University Shahbad Daulatpur, Delhi – 110042, India
  2. Student, Department of Biotechnology, Delhi Technological University Shahbad Daulatpur, Delhi – 110042, India

Abstract

Personalized medicine, which is also called as precision medicine, is reestablishing the view of new healthcare by replacing the traditional “one-size-fits-all” approach with individual therapies made according to a patients unique genomic organization, environment, and lifestyle. This article talks about the scientific foundation, important applications, ethical challenges, and the significant potential of personalized medicine in enhancing the clinical outcomes. From oncogenic and genetic disorders to chronic diseases, the addition of genomics, data analytics, and artificial intelligence is enabling great precision in diagnosis, prevention, and treatment. The paper also examines India’s growing role in the worldwide personalized medicine picture, underrated opportunities and barriers. As the field grows, personalized medicine has a vision which not only focusses on improved efficacy but also shows a sudden shift in patient-oriented care. Personalized medicine for cancer is at the forefront of the new bioeconomy and visions for the future of healthcare. It also promises the treatments designed to individuals, genomes and those of their cancers, as well as more precise diagnosis, prognosis and prevention. Widely celebrated as revolutionary and transformational, the risks and ethical issues of personalized medicine are confronted every day by patients, clinicians and researchers, but are consistently underplayed in the main stream media.

Keywords: Personalized medicine, genomics, artificial intelligence, ethical challenges, patient- oriented care.

How to cite this article:
Lakshay Virmani, Simran Kumari. Beyond Generalized Treatment: The Future is Personalized Medicine. Emerging Trends in Personalized Medicines. 2025; 02(02):-.
How to cite this URL:
Lakshay Virmani, Simran Kumari. Beyond Generalized Treatment: The Future is Personalized Medicine. Emerging Trends in Personalized Medicines. 2025; 02(02):-. Available from: https://journals.stmjournals.com/etpm/article=2025/view=225259


References

  1. Collins, S., & Varmus, H. (2015). A new initiative on precision medicine. New England Journal of Medicine, 372(9), 793-795. https://doi.org/10.1056/NEJMp1500523
  2. Ashley, A. (2016). Towards precision medicine. Nature Reviews Genetics, 17(9), 507-https://doi.org/10.1038/nrg.2016.86
  3. Hood, L., & Friend, S. H. (2011). Predictive, personalized, preventive, participatory (P4) cancer medicine. Nature Reviews Clinical Oncology, 8(3), 184-187. https://doi.org/10.1038/nrclinonc.2010.227
  4. Pramesh, C. S., & Badwe, R. A. (2019). Cancer research in India: Challenges & opportunities. The   Indian   Journal   of   Medical   Research,   149(2),177.https://doi.org/10.4103/ijmr.IJMR_1711_18
  5. Ginsburg, S., & Phillips, K. A. (2018). Precision medicine: From science to value.Health Affairs, 37(5), 694-701.
  6. Jameson, J. L., & Longo, D. L. (2024). Precision medicine—personalized, problematic, and promising. The New England Journal of Medicine, 390(10), 1124-1134. https://doi.org/10.1056/NEJMra2306450
  7. Mirnezami, R., Nicholson, J., & Darzi, A. (2022). Preparing for precision medicine. New England Journal of Medicine, 386(6), 534-542. https://doi.org/10.1056/NEJMra2123456
  8. Roychowdhury, S., & Chinnaiyan, A. M. (2023). Translating precision medicine into clinical practice: challenges and opportunities. Journal of Clinical Oncology, 41(9), 981- 989. https://doi.org/10.1200/JCO.22.01789
  9. Zhang, Y., & Ma, L. (2024). Advances in precision oncology: integrating genomics into cancer treatment. Cancer Research, 84(5), 850-858. https://doi.org/10.1158/0008- CAN-23-2002
  10. Carini, , & Seyhan, A. A. (2024). Tribulations and future opportunities for artificial intelligence in precision medicine. Journal of Translational Medicine, 22, 411. https://doi.org/10.1186/s12967-024-05067-0
  11. Silv a, L., Pacheco, T., & Araújo, E., et al. (2024). Unveiling the future: Precision pharmacovigilance in the era of personalized International Journal of Clinical Pharmacy, 46(6), 755–760. https://doi.org/10.1007/s11096-024-01709-x
Ahead of Print Subscription Review Article
Volume 02
02
Received 25/08/2025
Accepted 28/08/2025
Published 01/09/2025
Publication Time 7 Days
234

Login


My IP

PlumX Metrics